IP Library Granted Patent US 7,449,296
Granted Patent B2
US 7,449,296 · App. 11/361,184 · Granted Nov 11, 2008

Method and kit for detecting porcine reproductive and respiratory syndrome virus

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,449,296
App. No.
11/361,184
Granted
Nov 11, 2008
Kind
B2
Abstract

The invention provides methods, devices, and kits for the detection of a class of porcine reproductive and respiratory syndrome (PRRS) virus, or PRRSV, in a biological fluid. The invention is based in part on an agent which binds the nucleocapsid (N) protein of PRRSV. The agent may be an antibody that binds the N protein with specificity. Compositions and devices comprising the binding agent, as well as methods of using it are also provided. Also provided are methods of preparing devices and kits for the practice of the methods.

Claims (25)

1. A method of detecting the presence of nucleocapsid (N) protein of PRRSV in a sample of biological fluid from a subject, said method comprising

contacting said sample with at least one binding agent which binds the N protein of PRRSV to form at least one complex of binding agent bound to the N protein, and

detecting said complex,

wherein the presence of said binding agent in said complex indicates the presence of N protein in said sample.

2. The method of claim 1 wherein said sample of biological fluid is from a subject suspected of being infected with PRRSV.

3. The method of claim 2 wherein said sample is from a porcine subject.

4. The method of claim 1 wherein said biological fluid is selected from blood, serum, plasma, semen, seminal fluid, urine, saliva, tears, mucous, nasal secretions, vaginal secretions, and other bodily fluids or secretions.

5. The method of claim 1 wherein said at least one binding agent comprises an antibody.

6. The method of claim 5 wherein said antibody is a monoclonal antibody.

7. The method of claim 1 wherein said binding agent is labeled.

8. The method of claim 7 wherein said agent is labeled for direct detection.

9. The method of claim 1 wherein said detecting further comprises immobilization of said complex.

10. The method of claim 1 wherein the presence of said binding agent in said complex further indicates the subject as infected with PRRSV.

11. The method of claim 8 wherein said agent is labeled with a particulate label.

12. A method of detecting the presence of nucleocapsid (N) protein of PRRSV in a diluted sample of biological fluid from a subject, said method comprising

detecting a complex, comprising N protein of PRRSV and at least one binding agent which binds the N protein of PRRSV, said complex formed by contact between said diluted sample with said binding agent,

wherein the presence of said binding agent in said complex indicates the presence of N protein in said sample.

13. The method of claim 12 wherein said diluted sample is formed by dilution with a diluent containing a divalent cation chelator, EDTA, or from 1-5% bovine serum albumin in 0.01M KH 2 PO 4 and Na 2 HPO 4 and sodium azide.

14. The method of claim 12 wherein said sample is from a porcine subject.

15. The method of claim 12 wherein said biological fluid is selected from blood, serum, plasma, semen, seminal fluid, urine, saliva, tears, mucous, nasal secretions, vaginal secretions, and other bodily fluids or secretions.

16. The method of claim 12 wherein said at least one binding agent comprises an antibody.

17. The method of claim 16 wherein said antibody is a monoclonal antibody.

18. The method of claim 12 wherein said binding agent is labeled.

19. The method of claim 18 wherein said agent is labeled with a particulate label.

20. The method of claim 12 wherein the presence of said binding agent in said complex further indicates the subject as infected with PRRSV.

Assignments (5)
RELEASE OF SECURITY INTEREST IN PATENTS AT REEL 056139, FRAME 0578 Recorded Jul 17, 2024
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: PHIBRO ANIMAL HEALTH CORPORATION; OMNIGEN RESEARCH, LLC
Reel/Frame 068404/0557 →
SECURITY INTEREST Recorded Jul 15, 2024
From: PHIBRO ANIMAL HEALTH CORPORATION; PRINCE AGRI PRODUCTS, INC.; OMNIGEN RESEARCH, LLC
To: COÖPERATIEVE RABOBANK U.A., NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 068370/0043 →
SECURITY INTEREST Recorded May 5, 2021
From: PHIBRO ANIMAL HEALTH CORPORATION; OMNIGEN RESEARCH, LLC
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 056139/0578 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 8, 2018
From: MJ BIOLOGICS, INC.
To: PHIBRO ANIMAL HEALTH CORPORATION
Reel/Frame 046590/0368 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 26, 2006
From: JUNG, DONG-HYUK
To: MJ BIOLOGICS, INC.
Reel/Frame 017685/0060 →